Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase

EU orphan designation number: EU/3/16/1664   
Active ingredient: Polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase
Indication: Treatment of homocystinuria
Sponsor: Boyd Consultants Limited
Dublin City University, DCU Invent, Glasnevin, Dublin 9, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/06/2016 Orphan designation EMA/OD/025/16 (2016)3419 of 30/05/2016
27/03/2019 Transfer of orphan designation EMA/OD/0000004883 (2019)2383 of 25/03/2019